Skip to content
CAMP Logo
PennMedicine Logo
  • Clinical
    • Medications for Opioid Use Disorder (MOUD)
      • Buprenorphine Low-Dose Induction using a Cross-Tapering Strategy
      • Methadone Resources for Providers
    • Pain or Opioid Withdrawal in Hospitalized Patients
    • Xylazine Withdrawal and Overdose
    • Xylazine Wounds
    • Alcohol Use
    • Medetomidine
    • Substance Use Navigator Team
    • Success Stories
    • Penn Addiction Resources
  • Education
    • Students
      • President’s Engagement Prize
    • Trainings
    • Addiction Medicine Fellowship
    • All About the X Waiver
    • Working as a Peer in Recovery
    • Events
  • Community & Harm Reduction Resources
    • Community
      • Community Advisory Board (CAB)
      • Sustaining Peers in the ED (SPED)
      • Reentry Citizens
    • Harm Reduction
      • All About Fentanyl
      • All About Xylazine
      • How to Use Narcan
      • How to Mitigate Stigma
    • One-Page Resources
    • Volunteer & Events Calendar
      • Join Us at Outreach Events!
      • Volunteer Harm Reduction Interest Group
  • Our Work
    • CareConnect Warmline
    • Addiction Medicine Consult Service
    • Police-Assisted Diversion (PAD)
    • Project HOME
    • PROUD Clinic
    • Research
      • NACCHO
    • News
    • Policy
      • In Hospital Use Guidelines
    • Publications
    • Clinical Trials
  • About Us
    • Leadership
    • Advisory Board
    • Faculty
    • CAMP Team
    • Team Spotlight
    • Newsletters
    • Donate
  • Get Help
Posted on June 23, 2020 by admin

1
2
3

Posted in Uncategorized

Post navigation

Previous: Hello world!
Next: Nearly All Doctors Will be able to Prescribe Buprenorphine

Quick Links

Call the CareConnect Warmline

Micro-Dosing Guide

Addiction Medicine Fellowship

Resources

 

Contact Us:

484-278-1679

Email Address:

penncamp
@pennmedicine.upenn.edu

footer-bg
Center for Addiction Medicine and Policy

Contact Us with Questions or to Stay Informed of Upcoming Events
© 2025, Center for Addiction Medicine and Policy
  • Clinical
    • Medications for Opioid Use Disorder (MOUD)
      • Buprenorphine Low-Dose Induction using a Cross-Tapering Strategy
      • Methadone Resources for Providers
    • Pain or Opioid Withdrawal in Hospitalized Patients
    • Xylazine Withdrawal and Overdose
    • Xylazine Wounds
    • Alcohol Use
    • Medetomidine
    • Substance Use Navigator Team
    • Success Stories
    • Penn Addiction Resources
  • Education
    • Students
      • President’s Engagement Prize
    • Trainings
    • Addiction Medicine Fellowship
    • All About the X Waiver
    • Working as a Peer in Recovery
    • Events
  • Community & Harm Reduction Resources
    • Community
      • Community Advisory Board (CAB)
      • Sustaining Peers in the ED (SPED)
      • Reentry Citizens
    • Harm Reduction
      • All About Fentanyl
      • All About Xylazine
      • How to Use Narcan
      • How to Mitigate Stigma
    • One-Page Resources
    • Volunteer & Events Calendar
      • Join Us at Outreach Events!
      • Volunteer Harm Reduction Interest Group
  • Our Work
    • CareConnect Warmline
    • Addiction Medicine Consult Service
    • Police-Assisted Diversion (PAD)
    • Project HOME
    • PROUD Clinic
    • Research
      • NACCHO
    • News
    • Policy
      • In Hospital Use Guidelines
    • Publications
    • Clinical Trials
  • About Us
    • Leadership
    • Advisory Board
    • Faculty
    • CAMP Team
    • Team Spotlight
    • Newsletters
    • Donate
  • Get Help